Clinical Trial Update: Determining the Effects of Risperdal Consta in Patients With Psychotic Disorders and Incomplete Adherence [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating the effects of Risperdal Consta in patients with schizophrenia or schizoaffective disorder who have incomplete adherence; the …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizoaffective Disorder
• Schizophrenia

Drugs mentioned

• Risperdal Consta (risperidone long-acting injectable)

Snippet

Sponsor: Duke University | Conditions: Schizophrenia, Schizoaffective Disorder | Phase 4 | Status: COMPLETED